Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

3-(2-((3,4-dihydroxyphenyl)-(4-(2-dimethylaminoethyl)imidazol-1-yl)methyl)benzo(1,3)dioxol-5-yl)propionic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
3-(2-((3,4-dihydroxyphenyl)-(4-(2-dimethylaminoethyl)imidazol-1-yl)methyl)benzo(1,3)dioxol-5-yl)propionic acid
Unique ID
C000607981
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000607981
Entry Term(s)
LCB54-0009
Registry Numbers
0
Heading Mapped to
*Imidazoles
*Benzodioxoles
Frequency
1
Note
an inhibitor of both ocular angiogenesis and lymphangiogenesis; structure in first source
Source
Br J Pharmacol. 2015 Aug;172(15):3875-89.
Date of Entry
2016/05/29
Revision Date
2016/05/29
3-(2-((3,4-dihydroxyphenyl)-(4-(2-dimethylaminoethyl)imidazol-1-yl)methyl)benzo(1,3)dioxol-5-yl)propionic acid Preferred
LCB54-0009 Narrower
page delivered in 0.004s